Pierre Gholam MD

@livermd.bsky.social

6 years ago

@AASLDtweets dr. Don rockey presentation in a nutshell: FIBROSIS is the alpha and the omega in NAFLD. As little as 5% wt loss improves fibrosis #livermtg19 #steatofibrosis

Pierre Gholam MD

@livermd.bsky.social

6 years ago

@AASLDtweets dr. Watt @MayoClinic by far the strongest predictor of mortality and need for liver tx in NAFLD is the presence of FIBROSIS. #steatofibrosis #LiverMtg19

Pierre Gholam MD

@livermd.bsky.social

6 years ago

@AASLDtweets dr. Rinella @NorthwesternMed 100 mil with fatty liver but “only” 3.3 mil with F3-F4 fibrosis. Clarifies bulk of target population for therapeutics #steatofibrosis #LiverMtg19

Pierre Gholam MD

@livermd.bsky.social

7 years ago

in light of the recent negative #NASH study results for #selonsertib it is time to abandon the focus on inflammation and focus on the one thing that seem to truly matters: #steatofibrosis